Japanese Drug Companies Open Chemical Compound Libraries To DNDi In Effort To Improve NTD Therapies

New York Times: Japanese Companies Attack Neglected Diseases
“Several Japanese drug companies have joined a new project to find medicines to treat two neglected parasitic diseases, Chagas and leishmaniasis. Eisai Co., Shionogi & Co., and Takeda Pharmaceutical will join AstraZeneca, a London-based company, in opening their libraries of millions of chemical compounds to the Drugs for Neglected Diseases Initiative, allowing researchers to look for chemicals that kill the parasites in infected cells…” (McNeil, 6/1).